Latest Development, Product Innovations and Treatments for Diabetes

Report Code: HLC249A

Publish Date: Mar 2020

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rate (CAGR) of 5.0% for the period of 2019-2024.

Report Includes

  • 72 data tables and 33 additional tables
  • An overview of global market for diabetes treatment and discussion on latest developments and product innovations in the industry
  • Analyses of global market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Coverage of diabetes background, its prevalence and its threat to world health
  • Briefing about blood glucose monitoring and diagnostic systems and devices
  • Discussion on top drug treatments and their latest breakthroughs
  • Information on the artificial, or “Bionic” pancreas
  • A look at the measures taken to confront diabetes at the local, regional, national and trans-national level by raising awareness in parliaments and assemblies across the world
  • Evaluation of current market size, market forecast, and market share analysis of the leading suppliers of the industry
  • Insights into individual country policies and strategies to combat diabetes
  • Comprehensive company profiles of key players in the market, including Abbott Laboratories, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline PLC and NextCell Pharma AB

Report Scope

The key objectives of this study are to:

  • Review the impact that diabetes is having on global health. This includes:
    • Review of diabetes as a disease.
    • Review of the epidemiology of diabetes.
    • Data and statistics by region.
    • Predictions of future incidence and prevalence of diabetes globally and by region.
    • Review of the impact that diabetes has and will have in the future.
    • Review of the current products available within the following individual product segment and subsegments.
      • Blood glucose monitoring and diagnostic systems and devices.
      • Insulin-delivery devices.
      • Antidiabetic medications.
  • Review the latest technological advances and developments in blood glucose monitoring and diagnostic systems and devices. This includes:
    • Flash glucose monitoring (FGM).
    • New and novel approaches to blood glucose monitoring.
    • Review of the latest developments in continuous glucose monitoring (CGM) systems.
  • Review the latest technological advances and developments in insulin-delivery devices. This includes:
    • Insulin syringes.
    • Insulin pens and needles (reusable and disposable).
    • Insulin jet injectors.
    • External insulin pumps.
    • Implantable insulin pumps.
    • Insulin inhalers.
    • Insulin patches.
  • Review the latest technological advances and pipeline developments in Antidiabetic medications. This includes:
    • Review of the classification of Antidiabetic medications under the titles of injectable Antidiabetic medications and oral Antidiabetic drugs (OADS).
    • Review of the current product pipeline for new and innovative Antidiabetic medications.
    • Review the range of joint ventures, collaborations, licenses and research agreements currently focused on new medical device technologies.
    • Review of the regulatory requirements, intellectual property protection and concerns, patents and trademark process.
    • Review of the impact that the new and improved technologies will have on market dynamics by geographic region.
    • Survey of the key players involved in the development of new and innovative medical device technologies and Antidiabetic medications together with major improvements to existing technologies, as well as company profiles.

By purchasing this study, the reader will gain:

  • An improved understanding of the current state, future developments and latest product innovations in both medical devices and medications used to treat diabetes.
  • The latest information on the leading companies engaged in developing new and improving existing medical devices and medications, a review of the status of their product pipelines and insight into their proprietary technologies.
  • An understanding of the impact that these new products and technologies will have on the growth and development of the medical market.
  • An appreciation of how these new medical devices and medications will affect the provision of healthcare, how they will provide clinicians with new methods to treat existing conditions and how these technologies will improve clinical outcomes for patients.
  • An appreciation of the market restraints and drivers influencing the growth and development of this market.
  • The impact that diabetes has on the population and the implications as a global pandemic.

The analysis includes the use of charts and graphs measuring product growth and trends within the marketplace. Company-specific information, including sales figures, product pipeline status and R&D trends, is provided throughout the report.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

PAUL TAYLOR is an independent market researcher and analyst focused on the medical industry working on projects for over 20 years for a variety of prestigious clients including Agilent & Philips Medical Systems, Biomatrix, Inc (Genzyme Corporation), GE Medical Systems (Multiple Projects), Amersham Pharmacia Biotech Limited, Amersham Pharmacia Biotech Limited and Baxter Heathcare. He previously worked for multinational medical device and pharmaceutical companies including Bristol-Myers Squibb, Johnson & Johnson and Pfizer on developing and implementing strategic business and marketing plans. His predictive analytics knowledge and models of market research data have been used for biopharmaceutical and biotechnology clients. He has a bachelor's degree and Ph.D. degree in biochemistry from the University of Liverpool and an MBA degree for Oxford Brookes University.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Latest Development, Product Innovations and Treatments for Diabetes237Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights7Free
Chapter- 3: Introduction to Diabetes and Its Threat to World Health18Free
Chapter- 4: Blood Glucose Monitoring and Diagnostic Systems and Devices19Free
Chapter- 5: Insulin Delivery Devices34Free
Chapter- 6: Antidiabetic Medications25Free
Chapter- 7: Regional Markets for Diabetes Treatments15Free
Chapter- 8: Global Market for Glucose Monitoring and Diagnostic Products20Free
Chapter- 9: Global Market for Insulin Delivery Products and Devices13Free
Chapter- 10: Global Market for Antidiabetic Pharmaceuticals17Free
Chapter- 11: Company Profiles39Free
Chapter- 12: Appendix: A3Free
Chapter- 13: Appendix: B12Free
Chapter- 14: Appendix: C3Free
Chapter- 15: Appendix: D5Free

Related Reports

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Markets for Diabetes Therapeutics and Diagnostics

Published - Sep 2023 | Publisher - Bejini Sandeep Kumar | Code - HLC029F

The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.

Type 2 Diabetes Treatment: Global Market Outlook

Published - Jan 2023 | Publisher - BCC Publishing | Code - HLC287A

The goal is to provide an up-to-date analysis of the global type 2 diabetes treatment market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of the type 2 diabetes treatment. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Published - Jan 2023 | Publisher - BCC Publishing | Code - HLC102D

The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Latest Development, Product Innovations and Treatments for Diabetes
Customize Report